These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24098452)

  • 21. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
    Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
    J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
    Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
    PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
    Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
    Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
    Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
    Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
    Shang C; Lu YM; Meng LR
    Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
    Saetrom P; Biesinger J; Li SM; Smith D; Thomas LF; Majzoub K; Rivas GE; Alluin J; Rossi JJ; Krontiris TG; Weitzel J; Daly MB; Benson AB; Kirkwood JM; O'Dwyer PJ; Sutphen R; Stewart JA; Johnson D; Larson GP
    Cancer Res; 2009 Sep; 69(18):7459-65. PubMed ID: 19738052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.
    Hannafon BN; Sebastiani P; de las Morenas A; Lu J; Rosenberg CL
    Breast Cancer Res; 2011 Mar; 13(2):R24. PubMed ID: 21375733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good guy or bad guy: the opposing roles of microRNA 125b in cancer.
    Banzhaf-Strathmann J; Edbauer D
    Cell Commun Signal; 2014 Apr; 12():30. PubMed ID: 24774301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.
    Hesse JE; Liu L; Innes CL; Cui Y; Palii SS; Paules RS
    PLoS One; 2013; 8(5):e64779. PubMed ID: 23741392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.
    Chen W; Lu Q; Li S; Zhang X; Xue X
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33146718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
    Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
    Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
    Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
    Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
    Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
    Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
    Xu X; Lv YG; Yan CY; Yi J; Ling R
    Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
    Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
    Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.